Enhancement of percutaneous penetration of aniline and o-toluidine in vitro using skin barrier creams. 2008

Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
Institute and Out-Patient Clinic of Occupational, Social and Environmental Medicine, University Erlangen-Nuremberg, Schillerstrasse 25/29, D-91054 Erlangen, Germany. Gintautas.Korinth@rzmail.uni-erlangen.de

Aniline (ANI) and the human carcinogen o-toluidine (OT) are released at the workplace during the production and processing of rubber. Recently, we showed in rubber industry workers that a frequent use of skin barrier creams (SBC) increased the internal exposure of ANI and OT. In the present study, diffusion cells were used to investigate the effects of two SBC and one skin care cream (SCC) on percutaneous penetration of neat ANI and OT as well as of OT from a mixture with a workplace specific lubricant. The experiments were carried out with untreated and with skin creams treated human skin. A considerable percutaneous penetration enhancement of test compounds was observed for treated skin compared with untreated skin; the highest enhancement (mean factors 6.2-12.3) was found for SBC (based on oil in water emulsion) treated skin. The lowest penetration enhancement showed SCC treated skin (mean factors 4.2-9.7). The in vitro data support our findings in workers that the percutaneous absorption of aromatic amines significantly increases in presence of skin creams. The efficacy of skin creams to protect the percutaneous penetration of aromatic amines is not confirmed by our own experiments.

UI MeSH Term Description Entries
D005079 Excipients Usually inert substances added to a prescription in order to provide suitable consistency to the dosage form. These include binders, matrix, base or diluent in pills, tablets, creams, salves, etc. Excipient,Stabilizing Agent,Stabilizing Agents,Suspending Agent,Suspending Agents,Agent, Stabilizing,Agent, Suspending,Agents, Stabilizing,Agents, Suspending
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012869 Skin Absorption Uptake of substances through the SKIN. Absorption, Skin,Intracutaneous Absorption,Intradermal Absorption,Percutaneous Absorption,Transcutaneous Absorption,Transdermal Absorption,Absorption, Intracutaneous,Absorption, Intradermal,Absorption, Percutaneous,Absorption, Transcutaneous,Absorption, Transdermal,Absorptions, Intracutaneous,Absorptions, Intradermal,Absorptions, Percutaneous,Absorptions, Skin,Absorptions, Transcutaneous,Absorptions, Transdermal,Intracutaneous Absorptions,Intradermal Absorptions,Percutaneous Absorptions,Skin Absorptions,Transcutaneous Absorptions,Transdermal Absorptions
D012881 Skin Temperature The TEMPERATURE at the outer surface of the body. Skin Temperatures,Temperature, Skin,Temperatures, Skin
D014052 Toluidines Any of three isomeric compounds (ortho-, meta-, and para-) containing a benzene ring with a methyl and amino group attached to it. They are suspected CARCINOGENS. Aminotoluene
D054327 Lubricants Compounds that provide LUBRICATION between surfaces in order to reduce FRICTION. Lubricant,Lubricating Agents,Lubrication Agents,Agents, Lubricating,Agents, Lubrication
D020011 Protective Agents Synthetic or natural substances which are given to prevent a disease or disorder or are used in the process of treating a disease or injury due to a poisonous agent. Protective Agent,Protective Drug,Protective Drugs,Agent, Protective,Agents, Protective,Drug, Protective,Drugs, Protective
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
January 1996, Current problems in dermatology,
Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
September 2022, Chemical research in toxicology,
Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
January 1991, Acta chirurgiae plasticae,
Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
January 2002, Skin pharmacology and applied skin physiology,
Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
February 2024, International journal of cosmetic science,
Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
January 1994, Acta dermato-venereologica,
Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
September 1994, Acta dermato-venereologica,
Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
January 1992, Acta pharmaceutica Nordica,
Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
June 2003, International archives of occupational and environmental health,
Gintautas Korinth, and Lars Lüersen, and Karl Heinz Schaller, and Jürgen Angerer, and Hans Drexler
May 1991, American Industrial Hygiene Association journal,
Copied contents to your clipboard!